InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Tuesday, 10/02/2018 3:04:40 PM

Tuesday, October 02, 2018 3:04:40 PM

Post# of 1087
Corbus Pharmaceuticals granted U.S. patent related to cannabis Corbus Pharmaceuticals was granted a U.S. patent for ultrapure tetrahydrocannabinol-11-oic acid synthesis, pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of inflammation, pain, and fibrotic diseases including scleroderma, systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, idiopathic pulmonary fibrosis, Dupuytren's contracture, keloids, chronic kidney disease, chronic graft rejection, and other scarring-wound healing abnormalities, post-operative adhesions, and reactive fibrosis, according to a post to the USPTO site that has been passed among traders. Tetrahydrocannabinol, otherwise known as THC, is the active chemical in cannabis. Reference Link

Read more at:
https://thefly.com/news.php?symbol=CRBP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRBP News